C07D 407/00
Heterocyclic compounds containing two or more hetero rings, at least one ring
Official title: Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
C07D407/00 (Heterocyclic compounds containing two or more hetero rings, at least one ring) appears on 3,291 US grants and 3,503 published applications in this corpus.
Search patents in C07D- Granted patents
- 3,291
- Published applications
- 3,503
- Assignees
- 1,507
- Inventors
- 11,077
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 7 | 0 |
| 1978 | 8 | 0 |
| 1979 | 6 | 0 |
| 1980 | 9 | 0 |
| 1981 | 15 | 0 |
| 1982 | 8 | 0 |
| 1983 | 18 | 0 |
| 1984 | 17 | 0 |
| 1985 | 33 | 0 |
| 1986 | 25 | 0 |
| 1987 | 34 | 0 |
| 1988 | 34 | 0 |
| 1989 | 40 | 0 |
| 1990 | 37 | 0 |
| 1991 | 55 | 0 |
| 1992 | 46 | 0 |
| 1993 | 50 | 0 |
| 1994 | 37 | 0 |
| 1995 | 51 | 0 |
| 1996 | 45 | 0 |
| 1997 | 60 | 0 |
| 1998 | 47 | 0 |
| 1999 | 42 | 0 |
| 2000 | 62 | 0 |
| 2001 | 46 | 15 |
| 2002 | 62 | 58 |
| 2003 | 59 | 95 |
| 2004 | 54 | 113 |
| 2005 | 46 | 115 |
| 2006 | 54 | 86 |
| 2007 | 38 | 91 |
| 2008 | 60 | 95 |
| 2009 | 81 | 127 |
| 2010 | 75 | 136 |
| 2011 | 76 | 126 |
| 2012 | 105 | 170 |
| 2013 | 125 | 151 |
| 2014 | 170 | 192 |
| 2015 | 150 | 193 |
| 2016 | 157 | 181 |
| 2017 | 136 | 154 |
| 2018 | 130 | 156 |
| 2019 | 125 | 188 |
| 2020 | 160 | 216 |
| 2021 | 140 | 152 |
| 2022 | 106 | 140 |
| 2023 | 106 | 173 |
| 2024 | 98 | 150 |
| 2025 | 91 | 137 |
| 2026 | 50 | 93 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Amyloid targeting agents and methods of using the same22 Sep 2026US 12,741,949 B2Amydis, Inc.
- Quinoxaline derivatives and uses thereof22 Sep 2026US 12,741,976 B2Black Diamond Therapeutics, Inc.
- Compound for organic electric element, organic electric element using same, and electronic device thereof15 Sep 2026US 12,735,407 B2Duk San Neolux Co., Ltd.
- Organic electroluminescence device and polycyclic compound for organic electroluminescence device25 Aug 2026US 12,721,037 B2Samsung Display Co., Ltd.
- Substituted triazine compound28 Jul 2026US 12,692,241 B2Nico Therapeutics, Inc.
- Uric acid transporter agonist compound, pharmaceutical composition, and preparation method therefor and use thereof8 Oct 2026US 2026/0308136 A1Hangzhou E & J Biopharmaceutical Technology Co., Ltd.
- Novel carboxamide derivatives8 Oct 2026US 2026/0308149 A1Angelini Pharma S.P.A.
- Anthelmintic aza-benzothiophene and aza-benzofuran compounds8 Oct 2026US 2026/0308170 A1Boehringer Ingelheim Vetmedica GmbH
- Substituted triazine compound1 Oct 2026US 2026/0297040 A1
- Compounds for the degradation of mutant braf1 Oct 2026US 2026/0297060 A1C4 Therapeutics, Inc.
Most cited
By later US patents
- Photochromic indeno-fused naphthopyrans245US 5,645,767 ATransitions Optical, Inc. · 1997
- Recombinant production of novel polyketides221US 5,672,491 ALeland Stanford Junior University · 1997
- Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity220US 5,089,509 AAllergan, Inc. · 1992
- Intermediates useful for making 2,4-pyrimidinediamine compounds192US 7,060,827 B2Rigel Pharmaceuticals, Inc. · 2006
- Polymerizable polyalkoxylated naphthopyrans186US 6,113,814 ATransitions Optical, Inc. · 2000